Company / SG&A per Share
Erasca, Inc. SG&A per Share History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$0.18
FY2024
5-year range
$0.18 / $0.38
FY2020-FY2024
Trend
-28.9%
vs FY2023
Sector context
#201 of 210
Health Care
What the data says
Among 210 Health Care companies, Erasca, Inc. is in the top 4% for sg&a per share. SG&A per Share has declined for 4 consecutive years, from $0.38 in FY2020 to $0.18 in FY2024.
Based on SEC 10-K filings.
0.18 in FY2024 with a 3-year CAGR of -19.4%.
Improved from $0.27 to $0.18 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- -19.4%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 4% in Health CareTop 4% of 210This company $0.18 Sector average $29.50
▼
-99.4% below sector average
Key checks
Key Insights
- Erasca, Inc.'s sg&a per share has declined for 4 consecutive years.
- In FY2024, sg&a per share decreased 28.9% year-over-year.
- Ranks #201 out of 210 companies in the Health Care sector.
- Peak sg&a per share was recorded in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.18 | -28.9% |
| FY2023 | $0.25 | -7.1% |
| FY2022 | $0.27 | -20.7% |
| FY2021 | $0.34 | -9.8% |
| FY2020 | $0.38 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026